Japanese Prime Minister Shigeru Ishiba likes the nitty gritty of policy, cigarettes and making models, but his dream job as prime minister could go up in smoke this weekend.
Opinion polls suggest that Ishiba’s coalition could lose its majority in the upper house elections today, a result that might push him to resign.
The Liberal Democratic Party (LDP) has governed Japan almost continuously since 1955, but whether anyone wants to replace Ishiba is another matter.
Photo: Reuters
“I wonder who else wants the job,” said Masahisa Endo, a politics professor at Waseda University.
Ishiba, 68, a self-confessed defense “geek,” is the son of a regional governor and is from Japan’s small Christian minority. He won the party leadership in September last year, on his fifth try, to become the LDP’s 10th separate prime minister since 2000, all of them men.
Ishiba pledged to “create a new Japan” and revitalize depressed rural regions, and to address the “quiet emergency” of Japan’s shrinking population.
He immediately called lower house elections for October of that year, but that backfired spectacularly, with the LDP having its worst result in 15 years.
That robbed the LDP and its coalition party Komeito of their majority, forcing them to bargain with opposition parties to pass legislation.
Ishiba’s policies on bringing down inflation and spurring growth have “flip-flopped” as a result, Moody’s Analytics senior economist Stefan Angrick said.
“Ishiba’s government has boxed itself in, promising only some belated and half-hearted financial support that will do little to improve the demand outlook,” Angrick said.
The government’s popularity ratings have plummeted, with voters angry about price rises, especially for rice that is twice as expensive as a year ago.
Ishiba, the father of two daughters, also missed a chance to appear more modern by appointing only two women to his Cabinet, down from five under predecessor Fumio Kishida.
Ishiba’s sometimes clumsy ways — ranging from the less-than-perfectly tidy arrangement of his tuxedo to his table manners — have also been rich fodder for social media memes.
He drew ridicule after being snapped apparently napping in parliament and for failing to stand up to greet other world leaders at a gathering in South America.
Worse was a video that emerged of Ishiba eating an onigiri rice ball — a popular snack — whole and munching on it without closing his mouth.
“He eats like a three-year-old,” one user wrote on X.
“How could he have risen to the top with these manners?” another wrote.
A major challenge has been dealing with US President Donald Trump, who has imposed tariffs on Japanese cars, steel and aluminum.
Further levies of 25 percent on other Japanese imports would come into force on Aug. 1 if there is no trade agreement.
Ishiba secured an early invitation to the White House in February and has sent his tariffs envoy to Washington seven times, but there has been no deal yet.
Former Japanese prime minister Shinzo Abe — dubbed a “Trump whisperer” — fared better during Trump’s first term, managing to shield Japan from any tariffs.
Abe, who was assassinated in 2022, gifted Trump a gold-colored golf club and was a frequent visitor to see the US president.
Trump said that Abe nominated him for the Nobel Prize.
“There will never be another like him,” he said after Abe’s death.
FAKE NEWS? ‘When the government demands the press become a state mouthpiece under the threat of punishment, something has gone very wrong,’ a civic group said The top US broadcast regulator on Saturday threatened media outlets over negative coverage of the Middle East war, after US President Donald Trump slammed critical headlines from the “Fake News Media.” The US president since his first term has derided mainstream media as “fake news” and has sued major outlets over what he sees as unfair coverage. Brendan Carr, head of the US Federal Communications Commission — which oversees the nation’s radio, television and Internet media — said broadcasters risked losing their licenses over news coverage. “The law is clear. Broadcasters must operate in the public interest, and they will
INFLUTENTIAL THEORIST: Habermas was particularly critical of the ‘limited interest’ shown by German politicians in ‘shaping a politically effective Europe Jurgen Habermas, whose work on communication, rationality and sociology made him one of the world’s most influential philosophers and a key intellectual figure in his native Germany, has died. He was 96. Habermas’ publisher, Suhrkamp, said he died on Saturday in Starnberg, near Munich. Habermas frequently weighed in on political matters over several decades. His extensive writing crossed the boundaries of academic and philosophical disciplines, providing a vision of modern society and social interaction. His best-known works included the two-volume Theory of Communicative Action. Habermas, who was 15 at the time of Nazi Germany’s defeat, later recalled the dawn of
The Chinese public maintains relatively warm sentiments toward Taiwan and strongly prefers non-military paths to improving cross-strait relations, a recent survey conducted by the Atlanta, Georgia-based Carter Center and Emory University showed. The “China Pulse” research project, which polled 2,506 adults between Oct. 27 last year and Jan. 1 this year, found that 86 percent of respondents support strengthening cultural ties, while 81 percent favor deepening economic interaction. The report, co-authored by political scientists at Emory University and advisors at the Carter Center, indicates that the Chinese public views Taiwan’s importance through a lens of shared history and culture rather than geopolitical
Cannabis-based medicines have shown little evidence of effectiveness for treating most mental health and substance-use disorders, according to a large review of past studies published in a major medical journal on Monday. Medical use of cannabinoids has been expanding, including in the US, Canada and Australia, where many patients report using cannabis products to manage conditions such as anxiety, post-traumatic stress disorder and sleep problems. Researchers reviewed data from 54 randomized clinical trials conducted between 1980 and May last year involving 2,477 participants for their analysis published in The Lancet. The studies assessed cannabinoids as a primary treatment for mental disorders or substance-use
RSS